Pdt Partners, LLC Dyne Therapeutics, Inc. Transaction History

Pdt Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.2 - $15.17 $21,009 - $44,266	-2,918 Reduced 12.9%	19,705 $250,000
Q2 2022 Aug 15, 2022	SELL	$4.36 - $10.5 $20,108 - $48,426	-4,612 Reduced 16.93%	22,623 $155,000
Q1 2022 May 16, 2022	SELL	$6.52 - $12.27 $10,099 - $19,006	-1,549 Reduced 5.38%	27,235 $263,000
Q4 2021 Feb 14, 2022	BUY	$11.89 - $16.07 $181,619 - $245,469	15,275 Added 113.07%	28,784 $342,000
Q3 2021 Nov 15, 2021	BUY	$15.6 - $21.46 $210,740 - $289,903	13,509 New	13,509 $219,000

209

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.24B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.